Valeant CEO Pearson remains hospitalized for pneumonia: Bloomberg
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Dell again lifts annual forecasts as AI demand powers record results
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
- Comstock Resources signs $1.65B deal with SOCAR, $450M JV
Valeant Pharma (VRX) Tests $100 Level as Traders Await Pearson Update
December 29, 2015 11:10 AM ESTValeant Pharma (NYSE: VRX) has taken out yesterday's lows and is testing the $100 level with radio silence from the company about the condition of CEO Mike Pearson. Shares last traded at $100.06, down 2%.
Over the weekend, Pearson was hospitalized for severe pneumonia. Yesterday,... More
Valeant's (VRX) Walgreens (WBA) Deal Execution Seen as Area of Concern with Pearson on Leave - DJ
December 28, 2015 3:14 PM ESTIn the absence of CEO Mike Pearson, a key concern for Valeant Pharma (NYSE: VRX) will be executing the new drug distribution deal with Walgreens Boots Alliance (NASDAQ: WBA), Dow Jones reported.
Pearson handled much of the... More
Pershing Square Won't Comment on Valeant Pharma (VRX) CEO Medical Leave News
December 28, 2015 12:24 PM ESTPershing Square offered no comment to StreetInsider on news Valeant Pharma (NYSE: VRX) J. Michael Pearson will be on a medical leave of absence after being hospitalized with a severe case of pneumonia.
"PSCM is not commenting," a spokesperson said.
The... More
Valeant Pharma (VRX) CEO Hospitalized with Severe Pneumonia
December 28, 2015 6:13 AM ESTValeant Pharma (NYSE: VRX) CEO, Mike Pearson, has been hospitalized with severe pneumonia. The company does not expect his absence to disrupt operations since Mr. Pearson had scheduled an absence during the holiday period.
Commenting on the news, Mizho analyst Irina Koffler said, "We... More
